Gene expression profiling in postmortem Rett Syndrome brain: Differential gene expression and patient classification

Neurobiology of Disease

Volumn 8, Issue 5, 2001, Pages 847-865

  Colantuoni, Carlo ^a,b   Jeon, Ok Hee ^a,b   Hyder, Karim ^c   Chenchik, Alex ^c   Khimani, Anis H ^d   Narayanan, Vinodh ^e   Hoffman, Eric P ^f   Kaufmann, Walter E ^a,b,g   Naidu, SakkuBai ^a,b   Pevsner, Jonathan ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CLONTECH Laboratories Inc   (United States)

^d PERKINELMER INC   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETT SYNDROME; X CHROMOSOME INACTIVATION;

EID: 0035160042     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0428     Document Type: Article

References (98)

1. Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders
2. The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes
3. Methylation status of CpG sites and methyl-CpG binding proteins are involved in the promoter regulation of the mouse Xist gene
4. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome
5. Rett syndrome: Methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations
6. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
7. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
8. Review of Rett syndrome
9. Microscopic observations of the brain in Rett syndrome
10. Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome
11. Morphological study of neocortical areas in Rett syndrome
12. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents
13. MECP2 mutations account for most cases of typical forms of Rett syndrome
14. Molecular classification of cutaneous malignant melanoma by gene expression profiling
15. Dragon: Database referencing of array genes online
16. Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function
17. Diagnostic testing for rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: Identification of several novel mutations and polymorphisms
18. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
19. DNA methylation and gene activity
20. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation tyre and location
21. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
22. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males
23. High throughput analysis of gene expression in the human brain
24. Imprinting mechanisms
25. MECP2 is highly mutated in X-linked mental retardation
26. Preserved speech variant is allelic of classic Rett syndrome
27. Substance P immunoreactivity in Rett syndrome
28. Use of a cDNA microarray to analyse gene expression patterns in human cancer
29. Rett syndrome: A surprising result of mutation in MECP2
30. Microarray-based expression profiling in prostate tumors
31. Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers
32. Rosenthal fibers contain ubiquitinated alpha B-crystallin
33. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
34. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
35. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's Syndrome. Report of 35 cases
36. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
37. Mutations in the MECP2 gene in a cohort of girls with Rett syndrome
38. Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins
39. Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease
40. Quantitative 1H MR spectroscopic imaging in early Rett syndrome
41. Rett syndrome: Analysis of MECP2 and clinical characterization of 31 patients
42. MECP2 mutation in non-fatal, non-progressive encephalopathy in a male
43. Annexin VI binds to a synaptic vesicle protein, synapsin I
44. Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain
45. Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers
46. The cortical neuritic pathology of Huntington's disease
47. Neuropathology of Rett syndrome
48. Neuropathology of Rett syndrome
49. Cell death mechanisms in Parkinson's disease
50. Expression and structural analysis of 14-3-3 proteins
51. Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome
52. The neuroanatomy of Rett syndrome: Neuromorphological and neuroimaging studies
53. Abnormalities in neuronal maturation in Rett syndrome neocortex: Preliminary molecular correlates
54. Expression profiling in cancer using cDNA microarrays
55. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
56. Novel de novo nonsense mutation of MECP2 in a patient with Rett syndrome
57. Glial fibrillary acidic protein: Regulation by hormones, cytokines, and growth factors
58. Membrane cerebral lipids in Rett syndrome
59. Ubiquitin in neurodegenerative diseases
60. Alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease
61. Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin
62. Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies
63. A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males
64. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
65. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
66. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
67. Rett syndrome: A disorder affecting early brain growth
68. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin
69. Gene silencing by methyl-CpG-binding proteins
70. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
71. DNA methylation and chromatin modification
72. MECP2 mutations in Danish patients with Rett syndrome: High frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern
73. Quantitative aspects of reactive gliosis: A review
74. Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome
75. Rett syndrome: Spinal cord neuropathology
76. Rett syndrome: Cerebellar pathology
77. MECP2 mutation in male patients with non-specific X-linked mental retardation
78. Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females
79. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
80. Molecular portraits of human breast tumors
81. Postmorten brain abnormalities of the glutamate neurotransmitter system in autism
82. CpG methylation, chromatin structure and gene silencing-a three-way connection
83. Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson's disease
84. Expression of alpha B-crystallin in Alzheimer's disease
85. Systematic variation in gene expression patterns in human cancer cell lines
86. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations
87. 14-3-3 Proteins in neuronal development and function
88. Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold
89. Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females
90. Methyl-CpG-binding protein 2 mutations in Rett syndrome
91. Protein kinase C activation by acidic proteins including 14-3-3
92. Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots
93. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray
94. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein
95. Cell culture models for reactive gliosis: New perspectives
96. Mutation screening in Rett syndrome patients
97. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray
98. A dynamically regulated 14-3-3, Slob, and Slowpoke potassium channel complex in Drosophila presynaptic nerve terminals